Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,3.1435508305951206e-09,5.378207571138211,105.29407905334335,"['RPL41', 'RPL3', 'RPS7', 'RPLP1', 'RPSA', 'RPL23A', 'RPL10A', 'RPS15', 'RPS26', 'RPL7A', 'RPS25', 'RPS15A', 'RPS27', 'RPL18A', 'RPS18', 'RPLP2', 'RPL26', 'RPL15', 'FAU', 'RPL29', 'RPS27A', 'RPL19', 'RPS23']",1.3925930179536384e-06,0,0,23
2,"GPCRs, Class A Rhodopsin-like WP455",6.632179157047476e-09,4.201430030643514,79.11852548528047,"['NPFFR2', 'OXTR', 'GPR68', 'GPR87', 'PTGER3', 'HTR2B', 'OPRL1', 'FPR3', 'ADRA1D', 'MCHR1', 'GPR171', 'RHO', 'P2RY12', 'P2RY14', 'OR2H2', 'F2R', 'GPR3', 'SSTR1', 'GPR6', 'SSTR3', 'HCRTR2', 'TRHR', 'HCRTR1', 'MAS1', 'OPN1SW', 'ACKR4', 'NMUR2', 'GPR18']",1.469027683286016e-06,0,0,28
3,Tamoxifen metabolism WP691,0.00010578833464258618,18.44560878243513,168.85239957965504,"['CYP2A6', 'CYP1B1', 'CYP2C19', 'CYP3A4', 'CYP3A5']",0.01562141074888856,0,0,5
4,Pregnane X receptor pathway WP2876,0.00022063268829744452,7.388,62.19965535937118,"['HSP90AA1', 'CYP2A6', 'ABCB1', 'CYP2C19', 'CYP3A4', 'CYP3A5', 'CYP3A7']",0.02443507022894198,0,0,7
5,Peptide GPCRs WP24,0.0002941648009989659,4.485274003829671,36.47142427089108,"['OXTR', 'GNRHR', 'OPRL1', 'FPR3', 'SSTR1', 'SSTR3', 'TSHR', 'HCRTR2', 'TRHR', 'HCRTR1']",0.02606300136850838,0,0,10
6,Oxidation by Cytochrome P450 WP43,0.0004111870804674634,4.754437446321214,37.067792134003604,"['CYP39A1', 'CYP26B1', 'CYP2A6', 'CYP1B1', 'CYP3A4', 'CYP2C19', 'CYP3A5', 'CYP2C18', 'CYP3A7']",0.026337401440214365,0,0,9
7,Nuclear Receptors Meta-Pathway WP2882,0.0004161666141794595,2.0914682558662316,16.28087749120979,"['ABCB1', 'SRXN1', 'ABCB4', 'AMIGO2', 'SLC5A2', 'CYP2C19', 'CYP3A4', 'SLC5A3', 'CYP3A5', 'CYP3A7', 'DNAJB1', 'RGS2', 'ENC1', 'CYP1B1', 'HES1', 'SLC39A7', 'JUNB', 'SRGN', 'EGR1', 'JUN', 'HSP90AA1', 'GADD45B', 'SLC10A1', 'HGF', 'CYP2A6', 'SLC5A9', 'B3GNT5', 'BHLHE40', 'MAFF', 'FKBP5']",0.026337401440214365,0,0,30
8,Complement system WP2806,0.0006410472845880005,3.210764587525151,23.606849110238286,"['PRNP', 'FKBP2', 'SELPLG', 'CFH', 'ADM', 'PLG', 'SELE', 'SELP', 'FCGR3A', 'C6', 'SELL', 'MASP2', 'CD59']",0.035497993384060525,0,0,13
9,Tryptophan metabolism WP465,0.0010864295185904003,4.547316547316547,31.03479258363355,"['HAAO', 'ALDH1A1', 'AOX1', 'CYP1B1', 'DHCR24', 'CYP3A4', 'CYP2C18', 'ACMSD']",0.053476475192838595,0,0,8
10,Metapathway biotransformation Phase I and II WP702,0.001561356975054925,2.4485534961263116,15.82304235374918,"['CHST9', 'GLYAT', 'CYP2C19', 'CYP3A4', 'CYP2C18', 'CYP3A5', 'CYP3A7', 'CYP39A1', 'SULT1C2', 'CYP26B1', 'CYP2A6', 'CYP1B1', 'CHST13', 'GAL3ST2', 'NAT8L', 'SULT4A1', 'SULT1C4']",0.06315750308598365,0,0,17
11,Complement and Coagulation Cascades WP558,0.0015682449976203616,3.801746349842542,24.550910433684255,"['C1QA', 'CPB2', 'C6', 'CFH', 'SERPIND1', 'SERPINE1', 'F2R', 'MASP2', 'PLG']",0.06315750308598365,0,0,9
12,Constitutive Androstane Receptor Pathway WP2875,0.002036432346912819,5.5347152847152845,34.29617238500263,"['HSP90AA1', 'CYP2A6', 'ABCB1', 'CYP2C19', 'CYP3A4', 'CYP3A5']",0.07517829414019823,0,0,6
13,Glycolysis and Gluconeogenesis WP534,0.0023335591094015506,3.93993993993994,23.877457023064018,"['LDHC', 'LDHA', 'TPI1', 'PGAM1', 'ALDOC', 'ALDOB', 'ENO2', 'ALDOA']",0.07952051426652977,0,0,8
14,EDA signaling in hair follicle development WP3930,0.0025264015758636716,9.826520438683948,58.77201871304455,"['SOSTDC1', 'LTB', 'DKK1', 'RELB']",0.07994256415054332,0,0,4
15,Vitamin D Receptor Pathway WP2877,0.003322817646954149,2.3249243188698285,13.268208630778792,"['STEAP4', 'ABCB1', 'COL13A1', 'GADD45A', 'G0S2', 'CLDN2', 'CYP3A4', 'CYP3A5', 'SULT1C2', 'CEACAM1', 'S100A6', 'TIMP2', 'TIMP3', 'SOSTDC1', 'LGALS9', 'JUNB']",0.08995715493633175,0,0,16
16,Matrix Metalloproteinases WP129,0.0033823940562496607,6.145209580838324,34.96115132895988,"['MMP26', 'TIMP2', 'TIMP3', 'MMP19', 'TIMP4']",0.08995715493633175,0,0,5
17,Mitochondrial CIV Assembly WP4922,0.0034520804377373357,4.1342,23.43586285202908,"['COA3', 'PET100', 'NDUFA4', 'SCO2', 'COX14', 'HIGD1A', 'COX7C']",0.08995715493633175,0,0,7
18,Farnesoid X receptor pathway WP2879,0.0037710739548158607,8.422162085173053,46.99899497453036,"['SLC10A1', 'ABCB4', 'CYP3A4', 'FKBP5']",0.09281032011019034,0,0,4
19,Nicotine Metabolism WP1600,0.004059751291034711,inf,inf,"['CYP2A6', 'AOX1']",0.094656306417283,0,0,2
20,Fatty Acid Omega Oxidation WP206,0.0044642084037792296,14.72808764940239,79.70345243591703,"['CYP2A6', 'ALDH1A1', 'CYP3A4']",0.09888221614370993,0,0,3
21,Cori Cycle WP1946,0.007374898637039407,6.549684280491857,32.156808862842354,"['LDHA', 'TPI1', 'PGAM1', 'ALDOA']",0.1498876830161499,0,0,4
22,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.007443632113668845,11.045318725099602,54.12643969695377,"['HEY1', 'VEGFC', 'HES1']",0.1498876830161499,0,0,3
23,Heart Development WP1591,0.008853892018199546,3.8484124571081093,18.19105368764192,"['TBX1', 'HEY1', 'BHLHE40', 'SMYD1', 'VEGFC', 'FGF10']",0.17053365930706083,0,0,6
24,Vitamin A and carotenoid metabolism WP716,0.009284595562470436,3.3326774193548387,15.594926194644438,"['ALDH1A3', 'CYP26B1', 'RBP2', 'NPC1L1', 'ALDH1A1', 'LPL', 'LRAT']",0.17137815975726678,0,0,7
25,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.011349608100182304,8.835657370517929,39.571128269055414,"['HSD11B1', 'HSD11B2', 'HSD3B1']",0.19524946961029663,0,0,3
26,IL-18 signaling pathway WP4754,0.011459336816857138,1.7585910652920962,7.859056312826391,"['SLC12A3', 'JUN', 'BTG2', 'NRN1', 'CD81', 'MEPCE', 'FN1', 'IL18', 'FUT1', 'NR4A1', 'ARL4D', 'TNIP3', 'TIMP3', 'CYCS', 'LTB', 'PTPN7', 'NFKBIE', 'ATF3', 'SNTB1', 'IER3', 'ITM2C', 'ARF6', 'MYH7']",0.19524946961029663,0,0,23
27,Hypertrophy Model WP516,0.012714608706659579,5.358107495694734,23.388158801161993,"['NR4A3', 'WDR1', 'IL18', 'ATF3']",0.2086137650759331,0,0,4
28,Glucocorticoid Receptor Pathway WP2880,0.014610475071831767,2.5559195313704333,10.801358206438241,"['SRGN', 'RGS2', 'HSP90AA1', 'JUN', 'GADD45B', 'B3GNT5', 'ENC1', 'AMIGO2', 'BHLHE40']",0.23115858774362402,0,0,9
29,Cancer immunotherapy by PD-1 blockade WP4585,0.01611337545053886,4.911266201395812,20.27422540381194,"['ZAP70', 'JUN', 'CD8B', 'PDCD1LG2']",0.2397399975172794,0,0,4
30,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.016235214278822532,1.9639862260919212,8.092747977196932,"['EGR1', 'JUN', 'CAV3', 'CDCA7L', 'SSTR1', 'FOXM1', 'ADCYAP1', 'KCNQ1', 'BHLHE40', 'CHRFAM7A', 'HES1', 'ALDOA', 'YWHAG', 'YWHAH', 'NKX3-1']",0.2397399975172794,0,0,15
31,Photodynamic therapy-induced unfolded protein response WP3613,0.019024982759787958,3.685129740518962,14.600492439272292,"['XBP1', 'HSPA5', 'DDIT3', 'DNAJB9', 'ATF3']",0.27187314072858276,0,0,5
32,Adipogenesis WP236,0.019783099461427065,2.023032934448798,7.936211063274355,"['GDF10', 'EGR2', 'GADD45B', 'GADD45A', 'SERPINE1', 'EBF1', 'UCP1', 'LPL', 'PRLR', 'SFRP4', 'CYP26B1', 'DDIT3', 'LEP']",0.2738722831691309,0,0,13
33,ACE Inhibitor Pathway WP554,0.02209786286197551,6.310330108138873,24.056709789320774,"['MAS1', 'ATP6AP2', 'REN']",0.2910955147087515,0,0,3
34,Thyroxine (Thyroid Hormone) Production WP1981,0.02234141647877551,14.714427860696517,55.93414711888258,"['CGA', 'TSHR']",0.2910955147087515,0,0,2
35,VEGFA-VEGFR2 Signaling Pathway WP3888,0.023068276307648097,1.4693586537046888,5.538449055627587,"['SHB', 'RPL10A', 'ELK1', 'FUT1', 'APOLD1', 'HERPUD1', 'ACTG1', 'TUBB8', 'LDHA', 'RPL18A', 'ADAMTS1', 'RPLP2', 'DNAJB9', 'IER5', 'TMSB10', 'CLIC1', 'DUSP5', 'EGR1', 'JUN', 'HSP90AA1', 'EGR3', 'FN1', 'BMX', 'DKK1', 'SELE', 'DNAJA1', 'NR4A1', 'RCN1', 'NR4A3', 'TXNIP', 'CYCS', 'RPL26', 'ALDOA', 'DSC1', 'FJX1', 'ARF6']",0.2919784686939459,0,0,36
36,Proximal tubule transport WP4917,0.0253859208195916,2.6476153846153845,9.726175447238875,"['SLC22A6', 'ABCB1', 'SLC3A1', 'ATP6V0A4', 'SLC5A2', 'SLC22A8', 'ATP6V1B1']",0.31238785897441884,0,0,7
37,Selenium Micronutrient Network WP15,0.028026884982800294,2.2516049047247035,8.04856674400046,"['SERPINA3', 'SELENOM', 'RFK', 'SERPINE1', 'SELENOW', 'PLG', 'KMO', 'SEPHS2', 'SELENOH']",0.3208474318825789,0,0,9
38,Cells and molecules involved in local acute inflammatory response  WP4493,0.028970422743347983,5.521165338645418,19.553095932559074,"['SELP', 'SELPLG', 'C6']",0.3208474318825789,0,0,3
39,Computational Model of Aerobic Glycolysis WP4629,0.028970422743347983,5.521165338645418,19.553095932559074,"['LDHA', 'TPI1', 'ALDOA']",0.3208474318825789,0,0,3
40,Sulfation Biotransformation Reaction WP692,0.028970422743347983,5.521165338645418,19.553095932559074,"['SULT1C2', 'SULT4A1', 'SULT1C4']",0.3208474318825789,0,0,3
41,Aryl Hydrocarbon Receptor Pathway WP2873,0.03008254594088986,3.203809771760826,11.225541179311218,"['HSP90AA1', 'JUN', 'CYP1B1', 'HES1', 'JUNB']",0.3250382402881514,0,0,5
42,Prostaglandin Synthesis and Regulation WP98,0.031703924501073205,2.7643606393606395,9.540678799508376,"['HSD11B1', 'HSD11B2', 'ANXA3', 'PTGER3', 'S100A6', 'MITF']",0.33440091795179594,0,0,6
43,Sleep regulation WP3591,0.03450518809324855,3.0701097804391217,10.33597154311113,"['OXTR', 'IL18', 'CRH', 'HCRTR2', 'HCRTR1']",0.35474660181537754,0,0,5
44,SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms WP4883,0.0356736828878641,9.808955223880597,32.69660277751619,"['MAS1', 'REN']",0.35474660181537754,0,0,2
45,Drug Induction of Bile Acid Pathway WP2289,0.036835990256224305,4.907370517928287,16.20060372944443,"['ABCB1', 'SLC10A1', 'CYP3A4']",0.35474660181537754,0,0,3
46,Platelet-mediated interactions with vascular and circulating cells WP4462,0.036835990256224305,4.907370517928287,16.20060372944443,"['SELP', 'SELPLG', 'SELE']",0.35474660181537754,0,0,3
47,Spinal Cord Injury WP2431,0.039032493775104614,1.9335197934595525,6.271102315786866,"['SELP', 'EGR1', 'NR4A1', 'ACAN', 'BTG2', 'GADD45A', 'LEP', 'LTB', 'PDYN', 'ROS1', 'TNFSF13B']",0.36790201579513493,0,0,11
48,Cardiac Progenitor Differentiation WP2406,0.044500535038073497,2.8335636419468755,8.81876996749079,"['MESP1', 'ACTC1', 'THY1', 'DKK1', 'NODAL']",0.41070285462221995,0,0,5
49,Unfolded protein response WP4925,0.04788756535415972,3.2728481222997674,9.94585620893538,"['XBP1', 'HSPA5', 'DDIT3', 'TXNIP']",0.4329426826916889,0,0,4
50,Codeine and Morphine Metabolism WP1604,0.05127844968344348,7.356218905472637,21.851535702737543,"['ABCB1', 'CYP3A4']",0.43938224830097544,0,0,2
51,FTO Obesity Variant Mechanism WP3407,0.05127844968344348,7.356218905472637,21.851535702737543,"['TBX1', 'UCP1']",0.43938224830097544,0,0,2
52,Myometrial relaxation and contraction pathways WP289,0.05157534291569012,1.6950786654119823,5.025419333394817,"['OXTR', 'JUN', 'ADM', 'RXFP2', 'ACTG1', 'RGS4', 'RGS2', 'ACTC1', 'MAFF', 'CRH', 'CALM3', 'ATF3', 'YWHAG', 'YWHAH']",0.43938224830097544,0,0,14
53,Blood Clotting Cascade WP272,0.06614040250519622,3.679780876494024,9.994194653645415,"['F8A1', 'SERPINE1', 'PLG']",0.5472277683061816,0,0,3
54,Benzo(a)pyrene metabolism WP696,0.06881240244779524,5.884577114427861,15.749313196667309,"['CYP1B1', 'CYP3A4']",0.5472277683061816,0,0,2
55,Dual hijack model of Vif in HIV infection WP3300,0.06881240244779524,5.884577114427861,15.749313196667309,"['ELOB', 'RUNX1']",0.5472277683061816,0,0,2
56,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.06917551924412228,2.4550898203592815,6.557810666527407,"['IFITM3', 'JUN', 'IFITM2', 'DDIT3', 'JUNB']",0.5472277683061816,0,0,5
57,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.07450919257911368,2.023,5.253392695500173,"['JUN', 'FN1', 'NEFL', 'NEFM', 'ELK1', 'NEFH', 'PFN2']",0.563478041046992,0,0,7
58,"GPCRs, Other WP117",0.07450919257911368,2.023,5.253392695500173,"['ADGRE2', 'F2R', 'GPR55', 'GNRHR', 'ADRA1D', 'OR10A2', 'GPR18']",0.563478041046992,0,0,7
59,Circadian rhythm related genes WP3594,0.07620190212188557,1.534433276108352,3.9501972351247465,"['KLF10', 'EGR1', 'JUN', 'MAGEL2', 'EGR3', 'SERPINE1', 'OPRL1', 'CARTPT', 'HCRTR2', 'RELB', 'HCRTR1', 'PER2', 'LEP', 'BHLHE40', 'CRH', 'RPS27A']",0.563478041046992,0,0,16
60,Differentiation Pathway WP2848,0.07631756763616143,2.3757324061554312,6.112408164727073,"['HGF', 'FGF1', 'DKK1', 'NODAL', 'FGF10']",0.563478041046992,0,0,5
61,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.08025235168826678,2.6770597299012056,6.75309522627272,"['EGR2', 'RAB3A', 'RAB25', 'NEFL']",0.582816258982003,0,0,4
62,NRF2 pathway WP2884,0.08718126766215954,1.6557249405786412,4.039581070210927,"['EGR1', 'DNAJB1', 'HSP90AA1', 'CYP2A6', 'SLC5A9', 'SRXN1', 'HGF', 'MAFF', 'SLC39A7', 'SLC5A2', 'SLC5A3']",0.5904430811348801,0,0,11
63,Estrogen metabolism WP697,0.08796668928871804,4.903482587064676,11.91937109059894,"['CYP1B1', 'CYP3A4']",0.5904430811348801,0,0,2
64,HIF1A and PPARG regulation of glycolysis WP2456,0.08796668928871804,4.903482587064676,11.91937109059894,"['LDHA', 'TPI1']",0.5904430811348801,0,0,2
65,Irinotecan pathway WP229,0.08796668928871804,4.903482587064676,11.91937109059894,"['CYP3A4', 'CYP3A5']",0.5904430811348801,0,0,2
66,NAD Biosynthesis II (from tryptophan) WP2485,0.08796668928871804,4.903482587064676,11.91937109059894,"['HAAO', 'KMO']",0.5904430811348801,0,0,2
67,Complement Activation WP545,0.09003965936310236,3.153671030165054,7.592478918936715,"['C1QA', 'C6', 'MASP2']",0.5953368522067813,0,0,3
68,Hematopoietic Stem Cell Differentiation WP2849,0.09174121061934204,2.231446198512067,5.3304420692313785,"['TRAF3IP3', 'RHOH', 'FOSB', 'ABO', 'RUNX1']",0.5976670044760077,0,0,5
69,IL1 and megakaryocytes in obesity WP2865,0.1031506182941502,2.943227091633466,6.685731781900337,"['F2R', 'IL18', 'TIMP2']",0.6497239498145359,0,0,3
70,Kynurenine Pathway and links to Cellular Senescence WP5044,0.1031506182941502,2.943227091633466,6.685731781900337,"['HAAO', 'KMO', 'ACMSD']",0.6497239498145359,0,0,3
71,Phosphodiesterases in neuronal function WP4222,0.10413182942851477,1.9640359640359641,4.44284102464434,"['ADCY10', 'PDE10A', 'PDE3A', 'PDE6C', 'PDE5A', 'CHRFAM7A']",0.6497239498145359,0,0,6
72,Estrogen Receptor Pathway WP2881,0.10846392920356326,4.20270078180526,9.335617314453692,"['JUN', 'CYP1B1']",0.658212611468199,0,0,2
73,PTF1A related regulatory pathway WP4147,0.10846392920356326,4.20270078180526,9.335617314453692,"['HES1', 'FGF10']",0.658212611468199,0,0,2
74,Genotoxicity pathway WP4286,0.11174062338624575,1.9212092255570516,4.210474024095819,"['PLK3', 'BTG2', 'RPS27', 'SERTAD1', 'GADD45A', 'PCDH8']",0.6689337318933362,0,0,6
75,Imatinib and Chronic Myeloid Leukemia WP3640,0.11696193445578854,2.7590886454183265,5.920746930538967,"['SPRED2', 'ABCB1', 'GADD45A']",0.6817649600515042,0,0,3
76,RAS and bradykinin pathways in COVID-19 WP4969,0.11696193445578854,2.7590886454183265,5.920746930538967,"['SERPINE1', 'REN', 'CYP3A4']",0.6817649600515042,0,0,3
77,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.12091269638144098,2.2645908428560473,4.784370527345312,"['HSP90AA1', 'IL18', 'NLRC4', 'AAMP']",0.6867221089356199,0,0,4
78,Prion disease pathway WP3995,0.12091269638144098,2.2645908428560473,4.784370527345312,"['PRNP', 'HSPA5', 'EBF1', 'ELK1']",0.6867221089356199,0,0,4
79,"COVID-19, thrombosis and anticoagulation WP4927",0.12343243603928743,14.70079522862823,30.754965500611974,['PLG'],0.6921591033595484,0,0,1
80,Gene regulatory network modelling somitogenesis  WP2854,0.13005546113707167,3.6771144278606966,7.500557033385599,"['HES1', 'TBX6']",0.7099661953535161,0,0,2
81,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.13141586460268245,2.596613545816733,5.269537526113004,"['H2AFZ', 'DUSP6', 'HIST1H3E']",0.7099661953535161,0,0,3
82,Globo Sphingolipid Metabolism WP1424,0.13141586460268245,2.596613545816733,5.269537526113004,"['ST6GALNAC1', 'FUT1', 'ABO']",0.7099661953535161,0,0,3
83,Corticotropin-releasing hormone signaling pathway WP2355,0.13655864707971568,1.6369703036369703,3.2592096878036396,"['NR4A1', 'HSP90AA1', 'HSD3B1', 'IL18', 'CRH', 'FOSB', 'ELK1', 'JUNB']",0.7288612127266753,0,0,8
84,Glycolysis in senescence WP5049,0.1525188153636858,3.2683250414593696,6.145978402550769,"['LDHA', 'ALDOC']",0.7856492465827072,0,0,2
85,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.1525188153636858,3.2683250414593696,6.145978402550769,"['ZAP70', 'CD8B']",0.7856492465827072,0,0,2
86,Transcriptional cascade regulating adipogenesis WP4211,0.1525188153636858,3.2683250414593696,6.145978402550769,"['EGR2', 'DDIT3']",0.7856492465827072,0,0,2
87,Pre-implantation embryo WP3527,0.15609494158791698,2.0299102691924227,3.7701337833632214,"['EGR1', 'DDIT3', 'FOSB', 'AQP3']",0.7948282657867497,0,0,4
88,22q11.2 copy number variation syndrome WP4657,0.16497331963629194,1.5066268901439241,2.7148987432832263,"['SLC7A4', 'TBX1', 'CYP26B1', 'MRPL40', 'ACTC1', 'SERPIND1', 'HES1', 'RAN', 'FGF10']",0.8304906886236061,0,0,9
89,Serotonin and anxiety-related events WP3944,0.17565539002995909,2.9412935323383085,5.115589522588609,"['ARC', 'CRH']",0.8735378369918213,0,0,2
90,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.17804671664979765,2.2066733067729083,3.8080766697061286,"['POSTN', 'ANGPT2', 'SERPINE1']",0.8735378369918213,0,0,3
91,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.18141192100055883,1.8986910237030843,3.241037147997767,"['CREB3L1', 'HSD3B1', 'CALM3', 'REN']",0.8735378369918213,0,0,4
92,Vitamin B12 metabolism WP1533,0.18141192100055883,1.8986910237030843,3.241037147997767,"['SERPINA3', 'TCN1', 'SERPINE1', 'PLG']",0.8735378369918213,0,0,4
93,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.19448575465449408,2.101451337507114,3.4409087696097895,"['ABCB1', 'ABCB4', 'CYP3A4']",0.9101517980880885,0,0,3
94,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.19928831696285462,2.6737222976028945,4.312721215135366,"['POSTN', 'TNC']",0.9101517980880885,0,0,2
95,Development and heterogeneity of the ILC family WP3893,0.19928831696285462,2.6737222976028945,4.312721215135366,"['IL7', 'IL18']",0.9101517980880885,0,0,2
96,Major receptors targeted by epinephrine and norepinephrine WP4589,0.19928831696285462,2.6737222976028945,4.312721215135366,"['ADCY10', 'ADRA1D']",0.9101517980880885,0,0,2
97,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.19928831696285462,2.6737222976028945,4.312721215135366,"['JUN', 'TLR9']",0.9101517980880885,0,0,2
98,Oxidative Damage WP3941,0.20796776839038147,1.7833771413033626,2.800565833011051,"['C1QA', 'GADD45A', 'CYCS', 'NFKBIE']",0.9400991979279488,0,0,4
99,Striated Muscle Contraction Pathway WP383,0.21127772954469196,2.005795001810938,3.118172318583169,"['MYOM1', 'ACTC1', 'ACTG1']",0.9414469003632293,0,0,3
100,Melanoma WP4685,0.22216388746442303,1.5224775224775224,2.2903237412331134,"['GADD45B', 'GADD45A', 'MITF', 'CALM3', 'ELK1', 'GADD45G']",0.9414469003632293,0,0,6
101,ID signaling pathway WP53,0.22326050229761513,2.4507462686567165,3.6746882102128406,"['ELK1', 'PAX2']",0.9414469003632293,0,0,2
102,Breast cancer pathway WP4262,0.22785993432492685,1.3278359338995325,1.9639014293265935,"['SHC4', 'SFRP4', 'JUN', 'FRAT2', 'GADD45B', 'HEY1', 'GADD45A', 'HES1', 'FGF1', 'GADD45G', 'FGF10']",0.9414469003632293,0,0,11
103,White fat cell differentiation WP4149,0.22836799819000775,1.9184566083492118,2.8331708180769066,"['EGR2', 'DDIT3', 'EBF1']",0.9414469003632293,0,0,3
104,Aflatoxin B1 metabolism WP699,0.23164269106002708,4.899602385685885,7.165958639933968,['CYP3A4'],0.9414469003632293,0,0,1
105,COVID-19 adverse outcome pathway WP4891,0.23164269106002708,4.899602385685885,7.165958639933968,['IL7'],0.9414469003632293,0,0,1
106,Effects of nitric oxide WP1995,0.23164269106002708,4.899602385685885,7.165958639933968,['AOX1'],0.9414469003632293,0,0,1
107,Gastric acid production WP2596,0.23164269106002708,4.899602385685885,7.165958639933968,['GRP'],0.9414469003632293,0,0,1
108,Steroid Biosynthesis WP496,0.23164269106002708,4.899602385685885,7.165958639933968,['HSD3B1'],0.9414469003632293,0,0,1
109,Sulindac Metabolic Pathway WP2542,0.23164269106002708,4.899602385685885,7.165958639933968,['CYP1B1'],0.9414469003632293,0,0,1
110,Dopaminergic Neurogenesis WP2855,0.24743282816826834,2.2620742441637964,3.1592493883057897,"['ALDH1A1', 'SLC18A2']",0.9874276490529235,0,0,2
111,Tryptophan catabolism leading to NAD+ production WP4210,0.24743282816826834,2.2620742441637964,3.1592493883057897,"['HAAO', 'KMO']",0.9874276490529235,0,0,2
112,Copper homeostasis WP3286,0.24964310766123574,1.6344300432037222,2.268136081814485,"['PRNP', 'JUN', 'STEAP4', 'SCO2']",0.9874276490529235,0,0,4
113,Prader-Willi and Angelman Syndrome WP3998,0.25993026467915614,1.5011813108476924,2.022604474669986,"['PCSK1', 'MAGEL2', 'CGA', 'TYR', 'GABRD']",0.9988156921786608,0,0,5
114,Pathways in clear cell renal cell carcinoma WP4018,0.26739908560602205,1.3734,1.8115325007496499,"['LDHC', 'LDHA', 'TPI1', 'ALDOC', 'ALDOB', 'ENO2', 'ALDOA']",0.9988156921786608,0,0,7
115,MAPK pathway in congenital thyroid cancer WP4928,0.27168250280748457,2.100355366027008,2.7370175284780305,"['JUN', 'ELK1']",0.9988156921786608,0,0,2
116,Serotonin and anxiety WP3947,0.27168250280748457,2.100355366027008,2.7370175284780305,"['ARC', 'CRH']",0.9988156921786608,0,0,2
117,Folate Metabolism WP176,0.2783370225089272,1.548197512724983,1.9800247702731588,"['SERPINA3', 'RFK', 'SERPINE1', 'PLG']",0.9988156921786608,0,0,4
118,Composition of Lipid Particles WP3601,0.2806349502940395,3.6744532803180916,4.6691298538409045,['LPL'],0.9988156921786608,0,0,1
119,let-7 inhibition of ES cell reprogramming WP3299,0.2806349502940395,3.6744532803180916,4.6691298538409045,['EGR1'],0.9988156921786608,0,0,1
120,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.2928778346439611,1.5083978832732572,1.8523121534484228,"['HSP90AA1', 'JUN', 'ELK1', 'JUNB']",0.9988156921786608,0,0,4
121,Regulation of Microtubule Cytoskeleton WP2038,0.2928778346439611,1.5083978832732572,1.8523121534484228,"['PARD6A', 'CFL2', 'RHO', 'PHLDB2']",0.9988156921786608,0,0,4
122,15q13.3 copy number variation syndrome WP4942,0.29590154785654577,1.9601990049751243,2.3869901716391517,"['GOLGA8H', 'CHRFAM7A']",0.9988156921786608,0,0,2
123,BMP Signaling Pathway in Eyelid Development WP3927,0.29590154785654577,1.9601990049751243,2.3869901716391517,"['JUN', 'FGF10']",0.9988156921786608,0,0,2
124,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.29590154785654577,1.9601990049751243,2.3869901716391517,"['TNC', 'FN1']",0.9988156921786608,0,0,2
125,Base Excision Repair WP4752,0.2986893384917798,1.6337981407702524,1.9742020214446563,"['FEN1', 'NEIL2', 'POLE3']",0.9988156921786608,0,0,3
126,Genes controlling nephrogenesis WP4823,0.2986893384917798,1.6337981407702524,1.9742020214446563,"['KIRREL1', 'ITGA8', 'PAX2']",0.9988156921786608,0,0,3
127,Prolactin Signaling Pathway WP2037,0.30984064715578696,1.3372082462991555,1.566803097965625,"['ZAP70', 'JUN', 'CISH', 'ELK1', 'PRLR', 'YWHAG']",0.9988156921786608,0,0,6
128,Nanomaterial induced apoptosis WP2507,0.3199954117944424,1.8375621890547265,2.0938077031167777,"['ENDOG', 'CYCS']",0.9988156921786608,0,0,2
129,Nucleotide metabolism WP404,0.3199954117944424,1.8375621890547265,2.0938077031167777,"['PRPS1', 'OAZ1']",0.9988156921786608,0,0,2
130,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.32650624927432426,2.9393638170974157,3.2900481158793298,['CYP2C18'],0.9988156921786608,0,0,1
131,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.32650624927432426,2.9393638170974157,3.2900481158793298,['ABCB1'],0.9988156921786608,0,0,1
132,miRNA Biogenesis WP2338,0.32650624927432426,2.9393638170974157,3.2900481158793298,['RAN'],0.9988156921786608,0,0,1
133,Molybdenum cofactor (Moco) biosynthesis WP4507,0.32650624927432426,2.9393638170974157,3.2900481158793298,['AOX1'],0.9988156921786608,0,0,1
134,Fatty acid beta-oxidation WP143,0.33437446049816655,1.5209163346613546,1.6661543766079685,"['TPI1', 'LPL', 'ACSL5']",0.9988156921786608,0,0,3
135,Melatonin metabolism and effects WP3298,0.33437446049816655,1.5209163346613546,1.6661543766079685,"['PER2', 'CYP1B1', 'CYP2C19']",0.9988156921786608,0,0,3
136,Inflammatory Response Pathway WP453,0.3438816996607007,1.7293532338308457,1.846011212917513,"['ZAP70', 'FN1']",0.9988156921786608,0,0,2
137,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.3438816996607007,1.7293532338308457,1.846011212917513,"['HTR2B', 'ELK1']",0.9988156921786608,0,0,2
138,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.3438816996607007,1.7293532338308457,1.846011212917513,"['EGR1', 'ELK1']",0.9988156921786608,0,0,2
139,Exercise-induced Circadian Regulation WP410,0.35175373128686244,1.3677108210252962,1.4290170570341414,"['PER2', 'DNAJA1', 'G0S2', 'HERPUD1']",0.9988156921786608,0,0,4
140,Amyotrophic lateral sclerosis (ALS) WP2447,0.3522024090524481,1.4701195219123506,1.5341421141094154,"['NEFL', 'NEFM', 'NEFH']",0.9988156921786608,0,0,3
141,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.3522024090524481,1.4701195219123506,1.5341421141094154,"['LDHA', 'ANGPT2', 'SERPINE1']",0.9988156921786608,0,0,3
142,Endometrial cancer WP4155,0.3614097328846696,1.2897888433658997,1.3126735282848978,"['GADD45B', 'GADD45A', 'FGF1', 'ELK1', 'GADD45G']",0.9988156921786608,0,0,5
143,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.36748900978391724,1.633167495854063,1.6349017010964921,"['SELE', 'RELB']",0.9988156921786608,0,0,2
144,Purine metabolism and related disorders WP4224,0.36748900978391724,1.633167495854063,1.6349017010964921,"['PRPS1', 'AOX1']",0.9988156921786608,0,0,2
145,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.3694552169847057,2.4493041749502984,2.4388352240839613,['DHCR24'],0.9988156921786608,0,0,1
146,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.3694552169847057,2.4493041749502984,2.4388352240839613,['ALDH1A1'],0.9988156921786608,0,0,1
147,Tgif disruption of Shh signaling WP3674,0.3694552169847057,2.4493041749502984,2.4388352240839613,['NODAL'],0.9988156921786608,0,0,1
148,Signaling of Hepatocyte Growth Factor Receptor WP313,0.3699718413185149,1.4225999228890889,1.4145314778304894,"['JUN', 'HGF', 'ELK1']",0.9988156921786608,0,0,3
149,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.37889349326253946,1.2252747252747254,1.189129284831674,"['SFRP4', 'JUN', 'FRAT2', 'SFRP2', 'DKK1', 'ATF3']",0.9988156921786608,0,0,6
150,Angiogenesis WP1539,0.3907558696412479,1.5471065724011521,1.4537731731610128,"['TIMP2', 'TIMP3']",0.9988156921786608,0,0,2
151,Differentiation of white and brown adipocyte WP2895,0.3907558696412479,1.5471065724011521,1.4537731731610128,"['LEP', 'EBF3']",0.9988156921786608,0,0,2
152,Purinergic signaling WP4900,0.3907558696412479,1.5471065724011521,1.4537731731610128,"['P2RY12', 'P2RY14']",0.9988156921786608,0,0,2
153,Allograft Rejection WP2328,0.39601995495366216,1.2782521999219731,1.1840330965374048,"['C1QA', 'ABCB1', 'C6', 'HLA-C']",0.9988156921786608,0,0,4
154,Canonical NF-KB pathway WP4562,0.40966785315713217,2.099261573416643,1.8733990016892874,['NFKBIE'],0.9988156921786608,0,0,1
155,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.40966785315713217,2.099261573416643,1.8733990016892874,['ELOB'],0.9988156921786608,0,0,1
156,Liver X receptor pathway WP2874,0.40966785315713217,2.099261573416643,1.8733990016892874,['CYP3A4'],0.9988156921786608,0,0,1
157,Methylation Pathways WP704,0.40966785315713217,2.099261573416643,1.8733990016892874,['MAT2B'],0.9988156921786608,0,0,1
158,Mitochondrial CII Assembly WP4920,0.40966785315713217,2.099261573416643,1.8733990016892874,['SDHAF1'],0.9988156921786608,0,0,1
159,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.4106854038163731,1.2509704927769882,1.1132734165271476,"['BEX3', 'HSPA5', 'F2R', 'IER3']",0.9988156921786608,0,0,4
160,Oxidative phosphorylation WP623,0.4106854038163731,1.2509704927769882,1.1132734165271476,"['ATP6AP1', 'NDUFA4', 'ATP6AP2', 'ATP5MC3']",0.9988156921786608,0,0,4
161,TGF-beta Signaling Pathway WP366,0.41200265155070287,1.1309542161245567,1.0028459358155148,"['KLF10', 'JUN', 'PARD6A', 'TNC', 'FN1', 'NEDD9', 'FOSB', 'JUNB', 'ATF3']",0.9988156921786608,0,0,9
162,Estrogen signaling pathway WP712,0.41362976187217104,1.4696517412935324,1.297385043185691,"['JUN', 'ELK1']",0.9988156921786608,0,0,2
163,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.41362976187217104,1.4696517412935324,1.297385043185691,"['JUN', 'SRXN1']",0.9988156921786608,0,0,2
164,Zinc homeostasis WP3529,0.41362976187217104,1.4696517412935324,1.297385043185691,"['SLC30A2', 'SLC39A7']",0.9988156921786608,0,0,2
165,Lung fibrosis WP3624,0.42260710984496397,1.296812749003984,1.116960836209741,"['DSP', 'HGF', 'FGF1']",0.9988156921786608,0,0,3
166,DNA Mismatch Repair WP531,0.43606623444257486,1.3995735607675905,1.1615916586478,"['RPA3', 'POLE3']",0.9988156921786608,0,0,2
167,Modulators of TCR signaling and T cell activation WP5072,0.4397713125438299,1.199747695688445,0.9855932495819051,"['ZAP70', 'CD5', 'RHOH', 'ELOB']",0.9988156921786608,0,0,4
168,Fas ligand pathway and stress induction of heat shock proteins WP314,0.439832728876637,1.2596755833807627,1.0346481272625625,"['JUN', 'CYCS', 'ACTG1']",0.9988156921786608,0,0,3
169,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.439832728876637,1.2596755833807627,1.0346481272625625,"['HCK', 'CISH', 'RELB']",0.9988156921786608,0,0,3
170,Bile acids synthesis and enterohepatic circulation  WP4389,0.44731833020722694,1.8367296222664016,1.4776210439251518,['SLC10A1'],0.9988156921786608,0,0,1
171,"Degradation pathway of sphingolipids, including diseases WP4153",0.44731833020722694,1.8367296222664016,1.4776210439251518,['NEU1'],0.9988156921786608,0,0,1
172,Leptin and adiponectin WP3934,0.44731833020722694,1.8367296222664016,1.4776210439251518,['LEP'],0.9988156921786608,0,0,1
173,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.44731833020722694,1.8367296222664016,1.4776210439251518,['MAT2B'],0.9988156921786608,0,0,1
174,Role of Osx and miRNAs in tooth development WP3971,0.44731833020722694,1.8367296222664016,1.4776210439251518,['DKK1'],0.9988156921786608,0,0,1
175,Small Ligand GPCRs WP247,0.44731833020722694,1.8367296222664016,1.4776210439251518,['PTGER3'],0.9988156921786608,0,0,1
176,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.44731833020722694,1.8367296222664016,1.4776210439251518,['TBX6'],0.9988156921786608,0,0,1
177,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.44731833020722694,1.8367296222664016,1.4776210439251518,['ELK1'],0.9988156921786608,0,0,1
178,Trans-sulfuration pathway WP2333,0.44731833020722694,1.8367296222664016,1.4776210439251518,['MAT2B'],0.9988156921786608,0,0,1
179,Vitamin B12 Disorders WP4271,0.44731833020722694,1.8367296222664016,1.4776210439251518,['TCN1'],0.9988156921786608,0,0,1
180,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.45116433185628646,1.1481724051896207,0.913857552806659,"['SFRP4', 'JUN', 'FRAT2', 'SFRP2', 'DKK1']",0.9988156921786608,0,0,5
181,Canonical and non-canonical Notch signaling WP3845,0.45802808750572205,1.3358661239258254,1.043077359388154,"['HEY1', 'HES1']",0.9988156921786608,0,0,2
182,Gastric Cancer Network 1 WP2361,0.45802808750572205,1.3358661239258254,1.043077359388154,"['GATD3B', 'GATD3A']",0.9988156921786608,0,0,2
183,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.45802808750572205,1.3358661239258254,1.043077359388154,"['ZAP70', 'CD8B']",0.9988156921786608,0,0,2
184,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.46377174445664493,1.1304314448027022,0.8685814450902447,"['JUN', 'GADD45B', 'GADD45A', 'CYCS', 'GADD45G']",0.9988156921786608,0,0,5
185,Endochondral Ossification with Skeletal Dysplasias WP4808,0.46842163473593895,1.152542372881356,0.8740725298633962,"['ACAN', 'ADAMTS1', 'TIMP3', 'CTSV']",0.9988156921786608,0,0,4
186,Endochondral Ossification WP474,0.46842163473593895,1.152542372881356,0.8740725298633962,"['ACAN', 'ADAMTS1', 'TIMP3', 'CTSV']",0.9988156921786608,0,0,4
187,Aryl Hydrocarbon Receptor Netpath WP2586,0.47365803282702024,1.1914234952083558,0.8903146389840024,"['HSP90AA1', 'LPL', 'CYP1B1']",0.9988156921786608,0,0,3
188,Nephrotic syndrome WP4758,0.47365803282702024,1.1914234952083558,0.8903146389840024,"['MYO1E', 'EMP2', 'PAX2']",0.9988156921786608,0,0,3
189,NO/cGMP/PKG mediated Neuroprotection WP4008,0.47365803282702024,1.1914234952083558,0.8903146389840024,"['PDE3A', 'NEFL', 'CYCS']",0.9988156921786608,0,0,3
190,Cannabinoid receptor signaling WP3869,0.4794846308162247,1.2776984642007354,0.939163871461488,"['CYP2C19', 'CYP3A4']",0.9988156921786608,0,0,2
191,Ethanol effects on histone modifications WP3996,0.4794846308162247,1.2776984642007354,0.939163871461488,"['ALDH1A3', 'ALDH1A1']",0.9988156921786608,0,0,2
192,Ovarian infertility WP34,0.4794846308162247,1.2776984642007354,0.939163871461488,"['EGR1', 'PRLR']",0.9988156921786608,0,0,2
193,Cytokines and Inflammatory Response WP530,0.48256974456446744,1.6325381047051026,1.1895159459116205,['IL7'],0.9988156921786608,0,0,1
194,Dopamine metabolism WP2436,0.48256974456446744,1.6325381047051026,1.1895159459116205,['TYR'],0.9988156921786608,0,0,1
195,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.48256974456446744,1.6325381047051026,1.1895159459116205,['MAFF'],0.9988156921786608,0,0,1
196,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.48256974456446744,1.6325381047051026,1.1895159459116205,['FN1'],0.9988156921786608,0,0,1
197,Neuroinflammation WP4919,0.48256974456446744,1.6325381047051026,1.1895159459116205,['JUN'],0.9988156921786608,0,0,1
198,Valproic acid pathway WP3871,0.48256974456446744,1.6325381047051026,1.1895159459116205,['CYP2A6'],0.9988156921786608,0,0,1
199,Metabolic reprogramming in colon cancer WP4290,0.4902165423860859,1.1599916124973788,0.8269673727032074,"['LDHA', 'PGAM1', 'ALDOB']",0.9988156921786608,0,0,3
200,Electron Transport Chain (OXPHOS system in mitochondria) WP111,0.49344629216896957,1.0751200019492702,0.7594016130533895,"['NDUFA4', 'UCP1', 'ATP5MC3', 'SLC25A5', 'COX7A1', 'COX7C']",0.9988156921786608,0,0,6
201,Nonalcoholic fatty liver disease WP4396,0.4944360230288165,1.0495276266819353,0.7392216788004198,"['XBP1', 'JUN', 'NDUFB11', 'NDUFA4', 'DDIT3', 'LEP', 'CYCS', 'COX7A1', 'COX7C']",0.9988156921786608,0,0,9
202,16p11.2 distal deletion syndrome WP4950,0.5004110066908255,1.2243781094527364,0.8476681927495773,"['PLN', 'CD81']",0.9988156921786608,0,0,2
203,7-oxo-C and 7beta-HC pathways WP5064,0.5004110066908255,1.2243781094527364,0.8476681927495773,"['HSD11B1', 'HSD11B2']",0.9988156921786608,0,0,2
204,Toll-like Receptor Signaling related to MyD88 WP3858,0.5004110066908255,1.2243781094527364,0.8476681927495773,"['TLR9', 'RELB']",0.9988156921786608,0,0,2
205,Eukaryotic Transcription Initiation WP405,0.5065149589704631,1.1301716212074777,0.7687443435448799,"['TAF13', 'POLR2I', 'POLR2K']",0.9988156921786608,0,0,3
206,Oncostatin M Signaling Pathway WP2374,0.5103292950438096,1.0882906835050403,0.7320921470804544,"['EGR1', 'SERPINE1', 'TIMP3', 'JUNB']",0.9988156921786608,0,0,4
207,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.5155748203675967,1.4691848906560636,0.9732950939088618,['LPL'],0.9988156921786608,0,0,1
208,"NAD metabolism, sirtuins and aging WP3630",0.5155748203675967,1.4691848906560636,0.9732950939088618,['ROS1'],0.9988156921786608,0,0,1
209,Purine metabolism WP4792,0.5155748203675967,1.4691848906560636,0.9732950939088618,['PRPS1'],0.9988156921786608,0,0,1
210,Monoamine GPCRs WP58,0.5207875719778959,1.175323383084577,0.7667963150951678,"['HTR2B', 'ADRA1D']",0.9988156921786608,0,0,2
211,Small cell lung cancer WP4658,0.5265767656634388,1.036963036963037,0.6650646994714116,"['GADD45B', 'GADD45A', 'CKS2', 'FN1', 'CYCS', 'GADD45G']",0.9988156921786608,0,0,6
212,PDGFR-beta pathway WP3972,0.5405993357276313,1.1300420972062764,0.6950627605355031,"['JUN', 'ELK1']",0.9988156921786608,0,0,2
213,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.5405993357276313,1.1300420972062764,0.6950627605355031,"['ADAMTS2', 'CREB3L1']",0.9988156921786608,0,0,2
214,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.5464765684943962,1.335532260979577,0.80701386296977,['DKK1'],0.9988156921786608,0,0,1
215,Genes targeted by miRNAs in adipocytes WP1992,0.5464765684943962,1.335532260979577,0.80701386296977,['KCNQ1'],0.9988156921786608,0,0,1
216,Iron metabolism in placenta WP2007,0.5464765684943962,1.335532260979577,0.80701386296977,['HEPHL1'],0.9988156921786608,0,0,1
217,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.5464765684943962,1.335532260979577,0.80701386296977,['JUN'],0.9988156921786608,0,0,1
218,Osteoclast Signaling WP12,0.5464765684943962,1.335532260979577,0.80701386296977,['GPR68'],0.9988156921786608,0,0,1
219,Alzheimer's disease WP2059,0.5490397006850994,1.020043246839654,0.6116021461890518,"['ATP5MD', 'LPL', 'CYCS', 'CALM3', 'CDK5R1']",0.9988156921786608,0,0,5
220,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.5688238639091162,1.024761419438525,0.5781544542614684,"['XBP1', 'HSPA5', 'DDIT3']",0.9988156921786608,0,0,3
221,Hepatitis B infection WP4666,0.5749476271215584,0.978978978978979,0.5418416881248996,"['JUN', 'EGR2', 'EGR3', 'ATP6AP1', 'SLC10A1', 'CREB3L1', 'CYCS', 'ELK1']",0.9988156921786608,0,0,8
222,Cysteine and methionine catabolism WP4504,0.5754089034861685,1.224155069582505,0.6765591127974158,['SQOR'],0.9988156921786608,0,0,1
223,Ganglio Sphingolipid Metabolism WP1423,0.5754089034861685,1.224155069582505,0.6765591127974158,['FUT1'],0.9988156921786608,0,0,1
224,Nephrogenesis WP5052,0.5754089034861685,1.224155069582505,0.6765591127974158,['PAX2'],0.9988156921786608,0,0,1
225,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.5765634449008195,0.9957246903357724,0.5483156091448455,"['ANGPT2', 'TNIP3', 'FN1', 'ANGPTL1']",0.9988156921786608,0,0,4
226,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.5765634449008195,0.9957246903357724,0.5483156091448455,"['EGR1', 'JUN', 'CGA', 'TSHR']",0.9988156921786608,0,0,4
227,GABA receptor Signaling WP4159,0.5784887277284398,1.049182658137882,0.5742556679729334,"['GABRE', 'GABRD']",0.9988156921786608,0,0,2
228,DNA damage response WP707,0.5891877249593536,0.9790628115653041,0.5179344369977721,"['GADD45B', 'GADD45A', 'CYCS', 'GADD45G']",0.9988156921786608,0,0,4
229,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.5891877249593536,0.9790628115653041,0.5179344369977721,"['MYO1E', 'KIRREL2', 'DKK1', 'PAX2']",0.9988156921786608,0,0,4
230,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.6015884748933248,0.9629472239020643,0.48935212254308347,"['TUBB8', 'HSPA5', 'TUBA4A', 'HSPA1B']",0.9988156921786608,0,0,4
231,Fatty acid transporters WP5061,0.6024972219719998,1.1299128307080593,0.572495447383925,['ACSL5'],0.9988156921786608,0,0,1
232,Galanin receptor pathway WP4970,0.6024972219719998,1.1299128307080593,0.572495447383925,['UCP1'],0.9988156921786608,0,0,1
233,Leptin Insulin Overlap WP3935,0.6024972219719998,1.1299128307080593,0.572495447383925,['LEP'],0.9988156921786608,0,0,1
234,miR-509-3p alteration of YAP1/ECM axis WP3967,0.6024972219719998,1.1299128307080593,0.572495447383925,['FN1'],0.9988156921786608,0,0,1
235,Riboflavin and CoQ disorders WP5037,0.6024972219719998,1.1299128307080593,0.572495447383925,['RFK'],0.9988156921786608,0,0,1
236,MAPK Signaling Pathway WP382,0.6104266052685868,0.9512700011189437,0.46954422169456295,"['DUSP4', 'JUN', 'DUSP2', 'GADD45A', 'DUSP1', 'FGF1', 'ELK1', 'DUSP6', 'RELB', 'NR4A1', 'DDIT3', 'PTPN7', 'HSPA1B', 'FGF10']",0.9988156921786608,0,0,14
237,miRNA regulation of DNA damage response WP1530,0.6137603903564965,0.9473514939053806,0.4624502671565124,"['GADD45B', 'GADD45A', 'CYCS', 'GADD45G']",0.9988156921786608,0,0,4
238,Focal Adhesion WP306,0.6239165514006928,0.9386265994209396,0.4427864460712979,"['SHC4', 'HCK', 'JUN', 'CAV3', 'HGF', 'FN1', 'TNC', 'ITGA8', 'VEGFC', 'ELK1', 'ACTG1']",0.9988156921786608,0,0,11
239,RANKL/RANK signaling pathway WP2018,0.6260368463191116,0.9372933796727981,0.4389776517605341,"['JUN', 'MITF', 'RELB']",0.9988156921786608,0,0,3
240,Androgen receptor signaling pathway WP138,0.6272158445031848,0.9292175143384118,0.43344702780390415,"['JUN', 'RNF6', 'FKBP4', 'ETV5', 'RAN']",0.9988156921786608,0,0,5
241,ERK Pathway in Huntington's Disease WP3853,0.6278589437629647,1.0491337688156774,0.48830855863912337,['ELK1'],0.9988156921786608,0,0,1
242,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.6278589437629647,1.0491337688156774,0.48830855863912337,['CD81'],0.9988156921786608,0,0,1
243,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.6278589437629647,1.0491337688156774,0.48830855863912337,['GADD45G'],0.9988156921786608,0,0,1
244,Mitochondrial complex III assembly WP4921,0.6278589437629647,1.0491337688156774,0.48830855863912337,['UQCC3'],0.9988156921786608,0,0,1
245,Overview of nanoparticle effects WP3287,0.6278589437629647,1.0491337688156774,0.48830855863912337,['FN1'],0.9988156921786608,0,0,1
246,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.6278589437629647,1.0491337688156774,0.48830855863912337,['SFRP4'],0.9988156921786608,0,0,1
247,TP53 network WP1742,0.6278589437629647,1.0491337688156774,0.48830855863912337,['GADD45A'],0.9988156921786608,0,0,1
248,Disruption of postsynaptic signaling by CNV WP4875,0.630926302200138,0.9474562670518376,0.43636635011724273,"['ARC', 'YWHAG']",0.9988156921786608,0,0,2
249,MAPK Cascade WP422,0.630926302200138,0.9474562670518376,0.43636635011724273,"['JUN', 'ELK1']",0.9988156921786608,0,0,2
250,Calcium Regulation in the Cardiac Cell WP536,0.6355704649325998,0.9245781214285151,0.4190486809029773,"['RGS4', 'GJD2', 'RGS2', 'PLN', 'CALM3', 'ADRA1D', 'YWHAG', 'YWHAH']",0.9988156921786608,0,0,8
251,Pathogenic Escherichia coli infection WP2272,0.6394963006279507,0.9177041832669323,0.4102820863600772,"['TUBB8', 'TUBA4A', 'ACTG1']",0.9988156921786608,0,0,3
252,Microglia Pathogen Phagocytosis Pathway WP3937,0.6472359419085321,0.9177860696517413,0.3992776719292832,"['C1QA', 'HCK']",0.9988156921786608,0,0,2
253,p38 MAPK Signaling Pathway WP400,0.6472359419085321,0.9177860696517413,0.3992776719292832,"['DDIT3', 'ELK1']",0.9988156921786608,0,0,2
254,Parkinson's disease pathway WP2371,0.6472359419085321,0.9177860696517413,0.3992776719292832,"['PINK1', 'CYCS']",0.9988156921786608,0,0,2
255,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.6516040185751198,0.9791252485089463,0.4193771983155504,['SYTL5'],0.9988156921786608,0,0,1
256,Glycosaminoglycan degradation WP4815,0.6516040185751198,0.9791252485089463,0.4193771983155504,['HPSE2'],0.9988156921786608,0,0,1
257,Non-small cell lung cancer WP4255,0.6600782396975792,0.8896945527055198,0.36957636447113007,"['GADD45B', 'GADD45A', 'CYCS', 'GADD45G']",0.9988156921786608,0,0,4
258,Oxysterols derived from cholesterol WP4545,0.6629684495144899,0.889914066033469,0.36577948961935886,"['CYP39A1', 'CYP3A4']",0.9988156921786608,0,0,2
259,PPAR signaling pathway WP3942,0.6653823094184662,0.8808764940239043,0.3588633598511065,"['UCP1', 'ACSL5', 'LPL']",0.9988156921786608,0,0,3
260,TNF-alpha signaling pathway WP231,0.6680123203545261,0.8841954644927014,0.35672747707047187,"['HSP90AA1', 'JUN', 'RFK', 'NFKBIE', 'SELE']",0.9988156921786608,0,0,5
261,Canonical and non-canonical TGF-B signaling WP3874,0.673835401295155,0.9178677932405567,0.3623461268491977,['LOXL1'],0.9988156921786608,0,0,1
262,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.673835401295155,0.9178677932405567,0.3623461268491977,['ROS1'],0.9988156921786608,0,0,1
263,GDNF/RET signaling axis WP4830,0.673835401295155,0.9178677932405567,0.3623461268491977,['PAX2'],0.9988156921786608,0,0,1
264,"GPCRs, Class B Secretin-like WP334",0.673835401295155,0.9178677932405567,0.3623461268491977,['ADGRE2'],0.9988156921786608,0,0,1
265,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.673835401295155,0.9178677932405567,0.3623461268491977,['JUN'],0.9988156921786608,0,0,1
266,IL-2 signaling pathway WP49,0.6781310539153895,0.863681592039801,0.33546663930225473,"['JUN', 'CISH']",0.9988156921786608,0,0,2
267,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.6781310539153895,0.863681592039801,0.33546663930225473,"['GABRE', 'GABRD']",0.9988156921786608,0,0,2
268,Leptin signaling pathway WP2034,0.681776314221068,0.8634097706879362,0.33073227269913946,"['CISH', 'CFL2', 'LEP', 'ELK1']",0.9988156921786608,0,0,4
269,Development of ureteric collection system WP5053,0.6927324071860878,0.8389481165600569,0.3079874940920614,"['ITGA8', 'PAX2']",0.9988156921786608,0,0,2
270,IL-5 signaling pathway WP127,0.6927324071860878,0.8389481165600569,0.3079874940920614,"['JUN', 'ELK1']",0.9988156921786608,0,0,2
271,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.6927324071860878,0.8389481165600569,0.3079874940920614,"['JUN', 'RELB']",0.9988156921786608,0,0,2
272,Apoptosis Modulation by HSP70 WP384,0.6946494962585307,0.8638170974155069,0.31472993036297825,['CYCS'],0.9988156921786608,0,0,1
273,Methionine De Novo and Salvage Pathway WP3580,0.6946494962585307,0.8638170974155069,0.31472993036297825,['MAT2B'],0.9988156921786608,0,0,1
274,Nicotine Activity on Dopaminergic Neurons WP1602,0.6946494962585307,0.8638170974155069,0.31472993036297825,['SLC18A2'],0.9988156921786608,0,0,1
275,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.6946494962585307,0.8638170974155069,0.31472993036297825,['FN1'],0.9988156921786608,0,0,1
276,Transcription factor regulation in adipogenesis WP3599,0.6946494962585307,0.8638170974155069,0.31472993036297825,['LEP'],0.9988156921786608,0,0,1
277,ATM Signaling Pathway WP2516,0.7067823741146358,0.8155887230514096,0.28303577431131594,"['JUN', 'GADD45A']",0.9988156921786608,0,0,2
278,Ferroptosis WP4313,0.7067823741146358,0.8155887230514096,0.28303577431131594,"['PRNP', 'ACSL5']",0.9988156921786608,0,0,2
279,Ebstein-Barr virus LMP1 signaling WP262,0.7141365736944691,0.8157720344599072,0.2746549894054405,['HSP90AA1'],0.9988156921786608,0,0,1
280,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.7141365736944691,0.8157720344599072,0.2746549894054405,['LDHA'],0.9988156921786608,0,0,1
281,miRNA targets in ECM and membrane receptors WP2911,0.7141365736944691,0.8157720344599072,0.2746549894054405,['FN1'],0.9988156921786608,0,0,1
282,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.7141365736944691,0.8157720344599072,0.2746549894054405,['LDHA'],0.9988156921786608,0,0,1
283,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.7141365736944691,0.8157720344599072,0.2746549894054405,['NFKBIE'],0.9988156921786608,0,0,1
284,Glycogen Synthesis and Degradation WP500,0.7202918426624834,0.7934919994621488,0.26034378240873257,"['PHKA1', 'CALM3']",0.9988156921786608,0,0,2
285,PDGF Pathway WP2526,0.7202918426624834,0.7934919994621488,0.26034378240873257,"['JUN', 'ELK1']",0.9988156921786608,0,0,2
286,Apoptosis Modulation and Signaling WP1772,0.722201931908038,0.8152210036556996,0.26531407926419176,"['JUN', 'ENDOG', 'BIK', 'CYCS']",0.9988156921786608,0,0,4
287,One-carbon metabolism WP241,0.732381159624803,0.7727843465522654,0.24068692322036683,['MAT2B'],0.9988156921786608,0,0,1
288,"Relationship between inflammation, COX-2 and EGFR WP4483",0.732381159624803,0.7727843465522654,0.24068692322036683,['PTGER3'],0.9988156921786608,0,0,1
289,Triacylglyceride synthesis WP325,0.732381159624803,0.7727843465522654,0.24068692322036683,['LPL'],0.9988156921786608,0,0,1
290,Urea cycle and metabolism of amino groups WP497,0.732381159624803,0.7727843465522654,0.24068692322036683,['CKM'],0.9988156921786608,0,0,1
291,Vitamin D in inflammatory diseases WP4482,0.732381159624803,0.7727843465522654,0.24068692322036683,['DUSP1'],0.9988156921786608,0,0,1
292,Cell cycle WP179,0.7341714006307577,0.822523271121402,0.2541701876395872,"['GADD45B', 'GADD45A', 'CDC14A', 'YWHAG', 'GADD45G', 'YWHAH']",0.9988156921786608,0,0,6
293,p53 transcriptional gene network WP4963,0.7451823414247033,0.7723317257286643,0.2271631014062935,"['BTG2', 'GADD45A', 'SERPINE1']",0.9988156921786608,0,0,3
294,IL-6 signaling pathway WP364,0.7457369488392118,0.7526980482204363,0.22082832708890676,"['HCK', 'JUNB']",0.9988156921786608,0,0,2
295,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.7457369488392118,0.7526980482204363,0.22082832708890676,"['ACTC1', 'ACTG1']",0.9988156921786608,0,0,2
296,PI3K-Akt signaling pathway WP4172,0.7460474462924901,0.8618951612903226,0.2525060466643524,"['HSP90AA1', 'CSF3R', 'ANGPT2', 'HGF', 'F2R', 'FN1', 'TNC', 'VEGFC', 'FGF1', 'PRLR', 'IL7', 'CREB3L1', 'ITGA8', 'COL6A6', 'FGF10']",0.9988156921786608,0,0,15
297,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.7494624012264789,0.7340954274353877,0.21171248102314963,['HIST1H3E'],0.9988156921786608,0,0,1
298,Glycerolipids and Glycerophospholipids WP4722,0.7494624012264789,0.7340954274353877,0.21171248102314963,['CDIPT'],0.9988156921786608,0,0,1
299,IL-7 signaling pathway WP205,0.7494624012264789,0.7340954274353877,0.21171248102314963,['IL7'],0.9988156921786608,0,0,1
300,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.7494624012264789,0.7340954274353877,0.21171248102314963,['SCO2'],0.9988156921786608,0,0,1
301,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.7494624012264789,0.7340954274353877,0.21171248102314963,['BCL2L14'],0.9988156921786608,0,0,1
302,Statin inhibition of cholesterol production WP430,0.7494624012264789,0.7340954274353877,0.21171248102314963,['LPL'],0.9988156921786608,0,0,1
303,G1 to S cell cycle control WP45,0.7552433472781547,0.7589641434262948,0.21305282246095386,"['GADD45A', 'CREB3L1', 'RPA3']",0.9988156921786608,0,0,3
304,Endoderm differentiation WP2853,0.7639357248179854,0.7926667926667926,0.2134426738976102,"['DUSP4', 'DUSP5', 'DUSP2', 'ONECUT1', 'DKK1', 'NODAL']",0.9988156921786608,0,0,6
305,1q21.1 copy number variation syndrome WP4905,0.765454408537636,0.6990911672820221,0.18685701847035208,['KIRREL1'],0.9988156921786608,0,0,1
306,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.765454408537636,0.6990911672820221,0.18685701847035208,['TRPA1'],0.9988156921786608,0,0,1
307,Fatty Acid Biosynthesis WP357,0.765454408537636,0.6990911672820221,0.18685701847035208,['ACSL5'],0.9988156921786608,0,0,1
308,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.765454408537636,0.6990911672820221,0.18685701847035208,['CGA'],0.9988156921786608,0,0,1
309,NAD+ biosynthetic pathways WP3645,0.765454408537636,0.6990911672820221,0.18685701847035208,['ACMSD'],0.9988156921786608,0,0,1
310,IL-3 signaling pathway WP286,0.7691692501038401,0.7158839946608422,0.18787963271858707,"['HCK', 'JUN']",0.9988156921786608,0,0,2
311,Netrin-UNC5B signaling pathway WP4747,0.7691692501038401,0.7158839946608422,0.18787963271858707,"['JUN', 'SELE']",0.9988156921786608,0,0,2
312,TGF-beta Receptor Signaling WP560,0.7691692501038401,0.7158839946608422,0.18787963271858707,"['JUN', 'SERPINE1']",0.9988156921786608,0,0,2
313,Thermogenesis WP4321,0.7719813459967424,0.771877298035508,0.19975790234200813,"['ADCY10', 'CREB3L1', 'UCP1', 'ACSL5', 'ACTG1']",0.9988156921786608,0,0,5
314,Wnt signaling WP428,0.7719813459967424,0.771877298035508,0.19975790234200813,"['SFRP4', 'JUN', 'FRAT2', 'SFRP2', 'DKK1']",0.9988156921786608,0,0,5
315,Neural Crest Differentiation WP2064,0.7754900076273704,0.7522049236904671,0.19125576043750953,"['MIA', 'MITF', 'HES1', 'TBX6']",0.9988156921786608,0,0,4
316,Mesodermal commitment pathway WP2857,0.7778630080437441,0.7785312033099644,0.19557081610504334,"['TBX1', 'ARL4A', 'BHLHE40', 'TBX6', 'DKK1', 'NODAL']",0.9988156921786608,0,0,6
317,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.777916419776501,0.7893846153846154,0.19824304488484848,"['DSP', 'CLDN20', 'CLDN9', 'CLDN14', 'FN1', 'CLDN2', 'FOXM1']",0.9988156921786608,0,0,7
318,Nucleotide Excision Repair WP4753,0.7801643805149528,0.6987917555081734,0.17347549861135486,"['RPA3', 'POLE3']",0.9988156921786608,0,0,2
319,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.7801643805149528,0.6987917555081734,0.17347549861135486,"['CD160', 'CXCL17']",0.9988156921786608,0,0,2
320,EPO Receptor Signaling WP581,0.7804265749461377,0.6672691125971444,0.16542576704079984,['CISH'],0.9988156921786608,0,0,1
321,miRNA regulation of p53 pathway in prostate cancer WP3982,0.7804265749461377,0.6672691125971444,0.16542576704079984,['SERPINE1'],0.9988156921786608,0,0,1
322,Trans-sulfuration and one-carbon metabolism WP2525,0.7804265749461377,0.6672691125971444,0.16542576704079984,['MAT2B'],0.9988156921786608,0,0,1
323,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.7903816019125183,0.7773181818181818,0.18285587028035535,"['SHC4', 'EGR1', 'JUN', 'EGR2', 'RAB3A', 'ELK1', 'CDK5R1']",0.9988156921786608,0,0,7
324,Regulatory circuits of the STAT3 signaling pathway WP4538,0.7923142570830733,0.709805937540162,0.16524081820848527,"['DUSP2', 'CSF3R', 'F2R']",0.9988156921786608,0,0,3
325,miRNAs involvement in the immune response in sepsis WP4329,0.7944438770483334,0.638214193102256,0.14686134102840076,['RELB'],0.9988156921786608,0,0,1
326,MTHFR deficiency WP4288,0.7944438770483334,0.638214193102256,0.14686134102840076,['CYCS'],0.9988156921786608,0,0,1
327,Physiological and pathological hypertrophy of the heart WP1528,0.7944438770483334,0.638214193102256,0.14686134102840076,['JUN'],0.9988156921786608,0,0,1
328,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.7944438770483334,0.638214193102256,0.14686134102840076,['TLR9'],0.9988156921786608,0,0,1
329,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.7944438770483334,0.638214193102256,0.14686134102840076,['DKK1'],0.9988156921786608,0,0,1
330,Pancreatic adenocarcinoma pathway WP4263,0.7989413953918305,0.7241977770392526,0.16255899729953605,"['GADD45B', 'GADD45A', 'DUSP6', 'GADD45G']",0.9988156921786608,0,0,4
331,Histone Modifications WP2369,0.8007825828931542,0.6669380370872908,0.14817082312787624,"['SMYD1', 'HIST1H3E']",0.9988156921786608,0,0,2
332,Cell migration and invasion through p75NTR WP4561,0.8075671553506288,0.6115805168986084,0.13071253071717848,['JUN'],0.9988156921786608,0,0,1
333,Glycosylation and related congenital defects WP4521,0.8075671553506288,0.6115805168986084,0.13071253071717848,['DOLK'],0.9988156921786608,0,0,1
334,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.8090254481174672,0.687531125498008,0.14570496924947526,"['DSP', 'ITGA8', 'ACTG1']",0.9988156921786608,0,0,3
335,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.8104340547864716,0.6520729684908789,0.13705615559237064,"['JUN', 'SERPINE1']",0.9988156921786608,0,0,2
336,TYROBP causal network in microglia WP3945,0.8104340547864716,0.6520729684908789,0.13705615559237064,"['IGSF6', 'IL18']",0.9988156921786608,0,0,2
337,16p11.2 proximal deletion syndrome WP4949,0.8169466056014482,0.6769077536009807,0.13685825238509566,"['TBX6', 'ALDOA', 'CDIPT']",0.9988156921786608,0,0,3
338,Cytosolic DNA-sensing pathway WP4655,0.8196660961584844,0.6378542072247458,0.12684255319880167,"['IL18', 'POLR2K']",0.9988156921786608,0,0,2
339,Synaptic Vesicle Pathway WP2267,0.8196660961584844,0.6378542072247458,0.12684255319880167,"['RAB3A', 'SLC18A2']",0.9988156921786608,0,0,2
340,Gastric Cancer Network 2 WP2363,0.8198533776518094,0.5870775347912525,0.1166110712773988,['S100A6'],0.9988156921786608,0,0,1
341,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.8198533776518094,0.5870775347912525,0.1166110712773988,['PRLR'],0.9988156921786608,0,0,1
342,Oxidative Stress WP408,0.8198533776518094,0.5870775347912525,0.1166110712773988,['JUNB'],0.9988156921786608,0,0,1
343,Signal transduction through IL1R WP4496,0.8198533776518094,0.5870775347912525,0.1166110712773988,['JUN'],0.9988156921786608,0,0,1
344,Apoptosis WP254,0.8245868589998492,0.6666063020644694,0.12857022067578527,"['JUN', 'CYCS', 'NFKBIE']",0.9988156921786608,0,0,3
345,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.8284928986295615,0.624240499629512,0.1174489857176941,"['ZAP70', 'JUN']",0.9988156921786608,0,0,2
346,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.8313558849402041,0.5644593974613855,0.10425413499373917,['HGF'],0.9988156921786608,0,0,1
347,Intraflagellar transport proteins binding to dynein WP4532,0.8313558849402041,0.5644593974613855,0.10425413499373917,['DYNLL2'],0.9988156921786608,0,0,1
348,Nanoparticle-mediated activation of receptor signaling WP2643,0.8313558849402041,0.5644593974613855,0.10425413499373917,['FN1'],0.9988156921786608,0,0,1
349,B Cell Receptor Signaling Pathway WP23,0.8335880618043198,0.6818613925664866,0.12410963504741938,"['JUN', 'CD81', 'BLNK', 'ELK1']",0.9988156921786608,0,0,4
350,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.8378728175874053,0.7829321608664331,0.1384920549086931,"['HSP90AA1', 'CSF3R', 'ANGPT2', 'HGF', 'F2R', 'FN1', 'TNC', 'VEGFC', 'FGF1', 'PRLR', 'CREB3L1', 'ITGA8', 'FGF10']",0.9988156921786608,0,0,13
351,Autophagy WP4923,0.8421246222239149,0.5435166777115087,0.09339098600666045,['ATG101'],0.9988156921786608,0,0,1
352,Endothelin Pathways WP2197,0.8421246222239149,0.5435166777115087,0.09339098600666045,['ADCY10'],0.9988156921786608,0,0,1
353,Glycerophospholipid Biosynthetic Pathway WP2533,0.8421246222239149,0.5435166777115087,0.09339098600666045,['CDIPT'],0.9988156921786608,0,0,1
354,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.8421246222239149,0.5435166777115087,0.09339098600666045,['FGF1'],0.9988156921786608,0,0,1
355,Translation Factors WP107,0.8449869928225308,0.5986800690425423,0.10083810560163052,"['EIF4A2', 'EEF1G']",0.9988156921786608,0,0,2
356,Sphingolipid pathway WP1422,0.852206354696573,0.5240698665151945,0.08381270202529265,['SERINC1'],0.9988156921786608,0,0,1
357,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.8526819800806968,0.5866666666666667,0.09349626072444538,"['HES1', 'JUNB']",0.9988156921786608,0,0,2
358,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.8616448697315702,0.5059642147117296,0.07534418224070208,['PLG'],0.9988156921786608,0,0,1
359,Fluoropyrimidine Activity WP1601,0.8616448697315702,0.5059642147117296,0.07534418224070208,['CYP2A6'],0.9988156921786608,0,0,1
360,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.8616448697315702,0.5059642147117296,0.07534418224070208,['LPL'],0.9988156921786608,0,0,1
361,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.8704811664788307,0.48906560636182905,0.0678378771444118,['JUN'],0.9988156921786608,0,0,1
362,miRNA regulation of prostate cancer signaling pathways WP3981,0.8704811664788307,0.48906560636182905,0.0678378771444118,['CREB3L1'],0.9988156921786608,0,0,1
363,Neovascularisation processes WP4331,0.8704811664788307,0.48906560636182905,0.0678378771444118,['RELB'],0.9988156921786608,0,0,1
364,The influence of laminopathies on Wnt signaling WP4844,0.8704811664788307,0.48906560636182905,0.0678378771444118,['HES1'],0.9988156921786608,0,0,1
365,BDNF-TrkB Signaling WP3676,0.8787536333774074,0.4732572308086962,0.06116882890854531,['ARC'],0.9988156921786608,0,0,1
366,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.8787536333774074,0.4732572308086962,0.06116882890854531,['SUPT4H1'],0.9988156921786608,0,0,1
367,Neural Crest Cell Migration during Development WP4564,0.8787536333774074,0.4732572308086962,0.06116882890854531,['JUN'],0.9988156921786608,0,0,1
368,Kit receptor signaling pathway WP304,0.8800942543140664,0.5430624654505252,0.06936334312721659,"['MITF', 'JUNB']",0.9988156921786608,0,0,2
369,Regulation of Actin Cytoskeleton WP51,0.880664840446507,0.6656071201525747,0.08458412561542118,"['CFL2', 'F2R', 'FN1', 'FGF1', 'ACTG1', 'FGF10']",0.9988156921786608,0,0,6
370,3q29 copy number variation syndrome WP4906,0.8861697355986103,0.5331524197195839,0.06442974867118276,"['JUN', 'DYNLL2']",0.9988156921786608,0,0,2
371,MET in type 1 papillary renal cell carcinoma WP4205,0.8861697355986103,0.5331524197195839,0.06442974867118276,"['JUN', 'HGF']",0.9988156921786608,0,0,2
372,Notch Signaling Pathway Netpath WP61,0.8861697355986103,0.5331524197195839,0.06442974867118276,"['HEY1', 'HES1']",0.9988156921786608,0,0,2
373,Nuclear receptors WP170,0.8864982138067269,0.45843687872763417,0.055230718580508584,['NR4A1'],0.9988156921786608,0,0,1
374,Target Of Rapamycin (TOR) Signaling WP1471,0.8864982138067269,0.45843687872763417,0.055230718580508584,['RRAGA'],0.9988156921786608,0,0,1
375,Type 2 papillary renal cell carcinoma WP4241,0.8864982138067269,0.45843687872763417,0.055230718580508584,['ELOB'],0.9988156921786608,0,0,1
376,Amino Acid metabolism WP3925,0.8870379678097635,0.5785017823443069,0.069343558254579,"['AOC3', 'LDHA', 'ALDH1A1']",0.9988156921786608,0,0,3
377,ESC Pluripotency Pathways WP3931,0.88802322017035,0.6104187437686939,0.07249173528572661,"['JUN', 'FGF1', 'ELK1', 'FGF10']",0.9988156921786608,0,0,4
378,Male infertility WP4673,0.88802322017035,0.6104187437686939,0.07249173528572661,"['CYP26B1', 'ABCB1', 'TEX15', 'ETV5']",0.9988156921786608,0,0,4
379,AGE/RAGE pathway WP2324,0.8919588595561302,0.5235963041933192,0.05986552430808613,"['JUN', 'CYCS']",0.9988156921786608,0,0,2
380,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.8974734013700054,0.5143754909662215,0.05564092037549843,"['JUN', 'RELB']",0.9988156921786608,0,0,2
381,Proteasome Degradation WP183,0.8974734013700054,0.5143754909662215,0.05564092037549843,"['H2AFZ', 'HLA-C']",0.9988156921786608,0,0,2
382,Bladder cancer WP2828,0.9005361888591545,0.43141153081510936,0.04519679781603187,['DAPK2'],0.9988156921786608,0,0,1
383,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.9005361888591545,0.43141153081510936,0.04519679781603187,['TNFSF9'],0.9988156921786608,0,0,1
384,Neural Crest Cell Migration in Cancer WP4565,0.9005361888591545,0.43141153081510936,0.04519679781603187,['JUN'],0.9988156921786608,0,0,1
385,Regulation of toll-like receptor signaling pathway WP1449,0.9009922389315264,0.5918003565062389,0.061700297509438166,"['JUN', 'CISH', 'PELI3', 'TLR9']",0.9988156921786608,0,0,4
386,Pyrimidine metabolism WP4022,0.9014478418119002,0.5564198900600131,0.05773028578359675,"['POLE3', 'POLR2I', 'POLR2K']",0.9988156921786608,0,0,3
387,Gastrin signaling pathway WP4659,0.9050108999052164,0.5858424725822532,0.05847193613630708,"['EGR1', 'JUN', 'SERPINE1', 'ELK1']",0.9988156921786608,0,0,4
388,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.9068905978428417,0.419057086055098,0.04095589725654701,['HSD3B1'],0.9988156921786608,0,0,1
389,G13 Signaling Pathway WP524,0.9128394131530089,0.4073889993373095,0.037151963260151286,['CFL2'],0.9988156921786608,0,0,1
390,Hedgehog Signaling Pathway WP4249,0.9128394131530089,0.4073889993373095,0.037151963260151286,['EVC'],0.9988156921786608,0,0,1
391,Vitamin D-sensitive calcium signaling in depression WP4698,0.9128394131530089,0.4073889993373095,0.037151963260151286,['CALB1'],0.9988156921786608,0,0,1
392,ErbB signaling pathway WP673,0.9180769738459509,0.5294604713675419,0.04525512676366486,"['SHC4', 'JUN', 'ELK1']",0.9988156921786608,0,0,3
393,Senescence and Autophagy in Cancer WP615,0.9180769738459509,0.5294604713675419,0.04525512676366486,"['JUN', 'SERPINE1', 'FN1']",0.9988156921786608,0,0,3
394,Acute viral myocarditis WP4298,0.9254110374680932,0.465197820421701,0.03606086753326839,"['ENDOG', 'CYCS']",0.9988156921786608,0,0,2
395,Common Pathways Underlying Drug Addiction WP2636,0.9285028062313513,0.37597491971249425,0.027890524822900088,['ACTG1'],0.9988156921786608,0,0,1
396,DNA Replication WP466,0.9285028062313513,0.37597491971249425,0.027890524822900088,['RPA3'],0.9988156921786608,0,0,1
397,Ebola Virus Pathway on Host WP4217,0.9293078787168874,0.5472554299717669,0.040122133821118455,"['CAV3', 'HLA-C', 'ACTG1', 'RELB']",0.9988156921786608,0,0,4
398,Hepatitis C and Hepatocellular Carcinoma WP3646,0.933071929946598,0.3665506958250497,0.02539206113679283,['JUN'],0.9988156921786608,0,0,1
399,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.9373493194340498,0.35758619017601706,0.02313556188788361,['ATG101'],0.9988156921786608,0,0,1
400,Notch Signaling WP268,0.9373493194340498,0.35758619017601706,0.02313556188788361,['HES1'],0.9988156921786608,0,0,1
401,ATM Signaling Network in Development and Disease  WP3878,0.9413535844634048,0.34904856574836696,0.02109525829561316,['CDK5R1'],0.9988156921786608,0,0,1
402,Integrin-mediated Cell Adhesion WP185,0.9438940118120489,0.48265181034105337,0.027868988713904783,"['CAV3', 'ITGA8', 'RHO']",0.9988156921786608,0,0,3
403,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.9451021484545458,0.3409080401313052,0.01924843966868239,['DHCR24'],0.9988156921786608,0,0,1
404,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.9451021484545458,0.3409080401313052,0.01924843966868239,['ADCY10'],0.9988156921786608,0,0,1
405,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.9486113244033603,0.3331375384059281,0.01757504648197975,['EIF4A2'],0.9988156921786608,0,0,1
406,Toll-like Receptor Signaling Pathway WP75,0.9489133942740369,0.41847903340440656,0.02194409664141677,"['JUN', 'TLR9']",0.9988156921786608,0,0,2
407,DNA Repair Pathways Full Network WP4946,0.9501002131408536,0.5089080584333955,0.026049890241381952,"['FEN1', 'NEIL2', 'RPA3', 'POLE3']",0.9988156921786608,0,0,4
408,Integrated breast cancer pathway WP1984,0.9546490939284163,0.5298099453267379,0.024589246164233632,"['PLK3', 'JUN', 'GADD45A', 'RHO', 'FAU']",0.9988156921786608,0,0,5
409,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.9549716322395367,0.3186100786584839,0.014679527148971201,['ELK1'],0.9988156921786608,0,0,1
410,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.9549716322395367,0.3186100786584839,0.014679527148971201,['ARC'],0.9988156921786608,0,0,1
411,T-cell receptor (TCR) signaling pathway WP69,0.9566547960231927,0.4011994820418456,0.017778219173342696,"['ZAP70', 'JUN']",0.9988156921786608,0,0,2
412,IL-4 signaling pathway WP395,0.9578504520383438,0.31180999111712704,0.013427666202910771,['ELK1'],0.9988156921786608,0,0,1
413,Rett syndrome causing genes WP4312,0.9578504520383438,0.31180999111712704,0.013427666202910771,['GABRD'],0.9988156921786608,0,0,1
414,Interferon type I signaling pathways WP585,0.9630681513990573,0.2990424798149876,0.011253297403340213,['ZAP70'],0.9988156921786608,0,0,1
415,Mitochondrial complex I assembly model OXPHOS system WP4324,0.9630681513990573,0.2990424798149876,0.011253297403340213,['NDUFB11'],0.9988156921786608,0,0,1
416,DNA IR-damage and cellular response via ATR WP4016,0.9632656091262972,0.3852841057868552,0.01441967798865449,"['FEN1', 'FOXM1']",0.9988156921786608,0,0,2
417,Osteoblast differentiation WP4787,0.963809931150695,0.4389442231075697,0.016179997921550164,"['HEY1', 'FGF1', 'FGF10']",0.9988156921786608,0,0,3
418,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.9689019219302804,0.3705774922854084,0.011707242621320169,"['SHC4', 'HGF']",0.9988156921786608,0,0,2
419,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.9689019219302804,0.3705774922854084,0.011707242621320169,"['UCP1', 'TSHR']",0.9988156921786608,0,0,2
420,IL-1 signaling pathway WP195,0.9697099426353152,0.28173268083804864,0.008665612798884685,['JUN'],0.9988156921786608,0,0,1
421,Retinoblastoma gene in cancer WP2446,0.9705882591642389,0.36592039800995024,0.010923799158259799,"['H2AFZ', 'RPA3']",0.9988156921786608,0,0,2
422,EGF/EGFR signaling pathway WP437,0.9715041426622378,0.4903280686948251,0.01417525991382802,"['JUN', 'SPRY2', 'FOSB', 'ELK1', 'ARF6']",0.9988156921786608,0,0,5
423,Insulin Signaling WP481,0.9715041426622378,0.4903280686948251,0.01417525991382802,"['EGR1', 'XBP1', 'JUN', 'ELK1', 'ARF6']",0.9988156921786608,0,0,5
424,Ras signaling WP4223,0.9780382670661286,0.47115446526302235,0.010462683073550014,"['SHC4', 'ZAP70', 'CALM3', 'ELK1', 'ARF6']",0.9988156921786608,0,0,5
425,AMP-activated protein kinase (AMPK) signaling WP1403,0.9821506402872832,0.24403578528827038,0.004395226248044867,['LEP'],0.9988156921786608,0,0,1
426,Pathways affected in adenoid cystic carcinoma WP3651,0.9843617952440181,0.23613159751170398,0.0037218522634594148,['INSRR'],0.9988156921786608,0,0,1
427,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.9853625080257478,0.23236769857048187,0.0034264190430792997,['LPL'],0.9988156921786608,0,0,1
428,MECP2 and Associated Rett Syndrome WP3584,0.9862992322000733,0.22872142147117297,0.0031553239654460007,['FKBP5'],0.9988156921786608,0,0,1
429,Ciliopathies WP4803,0.9871289358342883,0.43694049027693116,0.005660395393928634,"['DNAH11', 'RSPH4A', 'EVC', 'CCDC65', 'CCNQ']",0.9988156921786608,0,0,5
430,DNA damage response (only ATM dependent) WP710,0.9887738356677257,0.3014412473713905,0.003403167179420349,"['JUN', 'BIK']",0.9988156921786608,0,0,2
431,Ectoderm Differentiation WP2858,0.9893357623064551,0.3534089448656985,0.003789076901913611,"['SPRY2', 'VAX2', 'LY6E']",0.9988156921786608,0,0,3
432,Hippo-Merlin Signaling Dysregulation WP4541,0.991583667982995,0.2865671641791045,0.002422051149803924,"['ITGA8', 'FOXM1']",0.9988156921786608,0,0,2
433,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9933822126764106,0.19502982107355865,0.0012949554893973046,['CISH'],0.9988156921786608,0,0,1
434,Glioblastoma signaling pathways WP2261,0.9952464800780112,0.18277833001988072,0.0008709120257229486,['SPRY2'],0.9988156921786608,0,0,1
435,Fragile X Syndrome  WP4549,0.9958149159917081,0.2561927206074889,0.0010744379360828635,"['ARC', 'GABRD']",0.9988156921786608,0,0,2
436,Pathways Regulating Hippo Signaling WP4540,0.9963520930702161,0.17402726498153934,0.000635995999572435,['PRKD3'],0.9988156921786608,0,0,1
437,G Protein Signaling Pathways WP35,0.9968043780546753,0.16995700217300846,0.0005439879795433163,['PRKD3'],0.9988156921786608,0,0,1
438,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9968802455533389,0.24534470504619757,0.0007666116773766434,"['LPL', 'CYP3A4']",0.9988156921786608,0,0,2
439,Chemokine signaling pathway WP3929,0.9975361127072536,0.2373012983861182,0.0005854051363029715,"['SHC4', 'HCK']",0.9988156921786608,0,0,2
440,Wnt signaling pathway and pluripotency WP399,0.9975476745110345,0.16235917826375082,0.00039864655681026375,['JUN'],0.9988156921786608,0,0,1
441,Ciliary landscape WP4352,0.9978519673360069,0.35502166398909496,0.0007634183483008495,"['USH1C', 'NEFL', 'COPS7A', 'NEFM', 'DYNLL2']",0.9988156921786608,0,0,5
442,7q11.23 copy number variation syndrome WP4932,0.9983513484128832,0.1521496023856859,0.0002510486862704225,['ATP5MC3'],0.9988156921786608,0,0,1
443,Genes related to primary cilium development (based on CRISPR) WP4536,0.9988156921786608,0.14456823415940004,0.00017131475516988937,['EVC'],0.9988156921786608,0,0,1
